Compliance of Blood Pressure and Lipid in Hypertensive Patients Under the Management of Hospitals at Different Levels

NCT04015843 | Unknown

• 1 other identifier: GUSU18006
• Study Type: observational
• Target: 1,800
• Locations: 1 country
• Sites: 1

Brief Summary

This is a multi-center, prospective cohort study that collects only diagnostic and therapeutic data in subjects but does not interfere with treatment.

Conditions

Hypertension

Outcome Measures

Primary Outcomes (1)

• The primary endpoint will be compliance of blood pressure in hypertensive patients after 3 months of treatment in hospitals at different levels.

  Blood pressure measurement: Blood pressure in both upper arms will be measured with a sphygmomanometer, with the patient in the sitting position. The mean value of three tests will be used for statistics. When left and right upper arms show different blood pressures, the higher value will be used for statistics.

  3 months

Secondary Outcomes (5)

• Percentage of outpatients with abnormal blood lipid levels in hospitals at different levels

  3 months

• Achievement rate of blood lipid levels in hypertensive and dyslipidemic patients after 3 months of treatment in hospitals at different levels

  3 months

• Compliance of patients towards antihypertensive and lipid-lowering treatments in hospitals at different levels

  3 months

• Factors affecting blood pressure and lipid compliance in different hospitals, such as patient adverse events

  3 months

• Achievement rate of blood pressure in hypertensive patients under different levels of hospital management after 1 month of treatment

  1 months

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Initial diagnosis of primary hypertension

You may qualify if:

• Patients meeting the following criteria will be included:
• Age ≥18 years, male or female;
• Agreement for blood pressure and lipid testing;
• Initial diagnosis of primary hypertension, with blood pressure conforming to the diagnostic criteria of the 2018 Guidelines for the Prevention and Treatment of Hypertension in China \[14\] (with no antihypertensive drugs, SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg after three tests performed on different days); or a history of primary hypertension but incompliant blood pressure;
• Willingness to participate in the study and signing of informed consent.

You may not qualify if:

• Patients meeting the following criteria will be excluded:
• Involvement in an interventional clinical research;
• Pregnancy or lactation in women;
• Complication with malignant tumors;
• Diagnosis of non-primary hypertension by researchers;
• Impaired cognitive ability;
• Researchers believing that the patients have other conditions not suitable for the study.

Sponsors & Collaborators

• China Cardiovascular Association: lead

Study Sites (1)

Wuhan Asia Heart Hospital

Wuhan, Hubei, China

RECRUITING

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular Diseases; Cardiovascular Diseases

Study Officials

• yong huo, master

  Peking University First Hospital

  PRINCIPAL INVESTIGATOR

Central Study Contacts

wei ma, doctor

CONTACT

13681050902; kmmawei@sina.com

jie wang, doctor

CONTACT

010-83572221; wang_jie116@126.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 3, 2019
• First Posted: July 11, 2019
• Study Start: August 22, 2019
• Primary Completion: August 30, 2020
• Study Completion: November 30, 2020
• Last Updated: November 25, 2019

Record last verified: 2019-06

Data Sharing

• IPD Sharing: Will not share

Locations

CN (1)